Home Tags Allergan

Tag: Allergan

A human brain and its millions of small nerves

The FDA just approved a new kind of medication that could change the way we treat a condition that affects 38 million Americans

The drug, Aimovig, is the first of a new class of medications that's going after the huge migraine market. An estimated 38 million Americans have migraines, and a large portion — roughly 15 million— would be eligible for preventive treatment.
Allergan CEO Brent Saunders

Investors are frustrated with Botox-maker Allergan — and its CEO says it’s ‘deep into the process’ of figuring out what to do ...

Allergan said Monday during its first-quarter earnings call that it's "deep into the process" of its strategic review of the company amid its stock price slipping over the past year.
Shire CEO Flemming Ornskov

A bidding war for the maker of Adderall stalled out after just 4 hours

Shire rejected a $60 billion bid from the Japanese drugmaker Takeda, while Allergan briefly considered getting into the fray on Thursday.
A human brain and its millions of small nerves

Allergan just got one step closer to approval for its migraine drug — and it’s part of a wave of new treatments for the condition that aff...

It's part of a wave of new migraine treatments that could potentially be approved in the next few years.

MORGAN STANLEY: Here are the 10 healthcare companies most likely to get bought this year

BI PRIME: Morgan Stanley compiled a list of large and liquid companies it thinks will get at least one tender offer over the next 12 months.
Pershing Square CEO Bill Ackman

The Bill Ackman problem everyone forgot is now at threat-level substantial

Investors in Allergan Pharmaceuticals are suing Ackman and Valeant over their 2014 attempted hostile takeover of the company.
Allergan CEO Brent Saunders

Allergan’s unusual deal with a Native American tribe could be backfiring

Analysts at Credit Suisse adjusted their model for Allergan, citing in part the response to a deal that gave Restasis patents sovereign immunity.
Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock Exchange (NYSE) April 6, 2016.

One of Allergan’s blockbuster drugs was dealt a major legal blow

Allergan, the drugmaker behind Botox, just got the patents on one of its blockbuster eye drug invalidated.
Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock Exchange (NYSE) April 6, 2016.

‘That should be illegal’: Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe

Allergan made a deal with a Native American tribe to protect its patents of the eye drug Restasis, and it's now coming under a lot of scrutiny.
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids and endometriosis with new medications.

‘Nobody’s talking about’ 2 medical conditions that affect 8 million women in America — but that could be about to change

The drugs in development are to treat two major women's health conditions: endometriosis and uterine fibroids.